(No ratings)
Dr. Peter Joseph Mogayzel, MD is a pediatric pulmonologist in Baltimore, MD specializing in pediatric pulmonology and general pediatrics. Dr. Peter Joseph Mogayzel, MD is affiliated with Frederick Health and Rubenstein Child Health Building.
He has a state license in Maryland.
Licensed In: Maryland
Dr. Peter Joseph Mogayzel, MD is associated with these hospitals and organizations:
Dr. Peter Joseph Mogayzel, MD does not have any reviews yet, be the first to leave a review of Dr. Peter Joseph Mogayzel, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Peter Joseph Mogayzel, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| AstraZeneca UK Limited |
$989
BREZTRI $989 |
|
|---|---|---|
| FOREST PHARMACEUTICALS, INC. |
$400
$400 |
|
| Theravance Biopharma Inc. |
$373
$373 |
|
| Amgen Inc. |
$300
$300 |
|
| Gilead Sciences Inc |
$221
Cayston $200 |
$21 |
| Other |
$574
(8874) InCourage $23 |
$551 |
| Consulting Fee | $1,106 |
|---|---|
| Travel and Lodging | $761 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400 |
| Food and Beverage | $390 |
| Honoraria | $200 |
Dr. Peter Joseph Mogayzel, MD has received 40 research payments totaling $283,681.
Dr. Peter Mogayzel is the Menowitz/Rosenstein Professor of Pediatric Respiratory Sciences at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pediatric pulmonary medicine and the treatment of cystic fibrosis. He has served as the director of the Johns Hopkins Cystic Fibrosis Center since 2002. Dr. Mogayzel attended Brown University and received his M.D. and Ph.D. degrees from Boston University and an M.B.A. from Johns Hopkins University. He completed his pediatric residency at the University of Washington, and finished pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty. His research interests include the regulatory properties of the CFTR gene, mucociliary clearance and development of new therapeutics for cystic fibrosis. Dr. Mogayzel has provided care for children with cystic fibrosis and has been active in the CF community since his arrival at Johns Hopkins. He served as Chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee and the Therapeutic Development Network Protocol Review Committee both of the Cystic Fibrosis Foundation. He is also a past Chairman of the Cystic Fibrosis Foundation Center Committee which accredits cystic fibrosis care centers in the US. He is currently a member of the Board of Directors of the Cystic Fibrosis Foundation.